185 related articles for article (PubMed ID: 38284712)
1. Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management.
Keyvani V; Naderi Ghale-Noie Z; Mollazadeh S; Alsadat Mahmoudian R; Ghorbani E; Naderi H; Khazaei M; Hassanian SM; A Ferns G; Avan A; Anvari K
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38284712
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer.
Shimizu A; Sawada K; Kimura T
Cells; 2020 Mar; 9(4):. PubMed ID: 32230983
[TBL] [Abstract][Full Text] [Related]
3. Exosomes in cancer development and clinical applications.
Tai YL; Chen KC; Hsieh JT; Shen TL
Cancer Sci; 2018 Aug; 109(8):2364-2374. PubMed ID: 29908100
[TBL] [Abstract][Full Text] [Related]
4. The Roles of Exosomes in Ovarian Cancer Chemo-resistance.
Liu Y; Li X; Zhang T; Liu G
J Cancer; 2023; 14(11):2128-2144. PubMed ID: 37497408
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Fanale D; Corsini LR; Bono M; Randazzo U; Barraco N; Brando C; Cancelliere D; Contino S; Giurintano A; Magrin L; Pedone E; Perez A; Piraino P; Pivetti A; Giovanni ED; Russo TDB; Prestifilippo O; Gennusa V; Pantuso G; Russo A; Bazan V
Crit Rev Oncol Hematol; 2024 Jan; 193():104220. PubMed ID: 38036154
[TBL] [Abstract][Full Text] [Related]
6. Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target.
Nakamura K; Sawada K; Kobayashi M; Miyamoto M; Shimizu A; Yamamoto M; Kinose Y; Kimura T
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31405096
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
8. Role of exosomes in the immune microenvironment of ovarian cancer.
Li X; Liu Y; Zheng S; Zhang T; Wu J; Sun Y; Zhang J; Liu G
Oncol Lett; 2021 May; 21(5):377. PubMed ID: 33777201
[TBL] [Abstract][Full Text] [Related]
9. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
Sharma S; Salomon C
Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
[TBL] [Abstract][Full Text] [Related]
10. Exosomes as Therapeutic Vehicles for Cancer.
Lim W; Kim HS
Tissue Eng Regen Med; 2019 Jun; 16(3):213-223. PubMed ID: 31205851
[TBL] [Abstract][Full Text] [Related]
11. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
[TBL] [Abstract][Full Text] [Related]
12. The exosome: a review of current therapeutic roles and capabilities in human reproduction.
Dimik M; Abeysinghe P; Logan J; Mitchell M
Drug Deliv Transl Res; 2023 Feb; 13(2):473-502. PubMed ID: 35980542
[TBL] [Abstract][Full Text] [Related]
13. Exosome-Based Delivery of Natural Products in Cancer Therapy.
Song H; Liu B; Dong B; Xu J; Zhou H; Na S; Liu Y; Pan Y; Chen F; Li L; Wang J
Front Cell Dev Biol; 2021; 9():650426. PubMed ID: 33738290
[TBL] [Abstract][Full Text] [Related]
14. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
[TBL] [Abstract][Full Text] [Related]
15. Impact of exosome therapy on pancreatic cancer and its progression.
El-Tanani M; Nsairat H; Matalka II; Aljabali AAA; Mishra V; Mishra Y; Naikoo GA; Chava SR; Charbe NB; Tambuwala MM
Med Oncol; 2023 Jul; 40(8):225. PubMed ID: 37405480
[TBL] [Abstract][Full Text] [Related]
16. Exosomes: A potential tool for immunotherapy of ovarian cancer.
Gong X; Chi H; Strohmer DF; Teichmann AT; Xia Z; Wang Q
Front Immunol; 2022; 13():1089410. PubMed ID: 36741380
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and stoichiometric analysis of the microRNA content of exosomes.
Chevillet JR; Kang Q; Ruf IK; Briggs HA; Vojtech LN; Hughes SM; Cheng HH; Arroyo JD; Meredith EK; Gallichotte EN; Pogosova-Agadjanyan EL; Morrissey C; Stirewalt DL; Hladik F; Yu EY; Higano CS; Tewari M
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14888-93. PubMed ID: 25267620
[TBL] [Abstract][Full Text] [Related]
18. Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer.
Jiang L; Gu Y; Du Y; Liu J
Mol Pharm; 2019 Aug; 16(8):3333-3349. PubMed ID: 31241965
[TBL] [Abstract][Full Text] [Related]
19. Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy.
Bhatia R; Chang J; Munoz JL; Walker ND
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371709
[TBL] [Abstract][Full Text] [Related]
20. Alternating exosomes and their mimetics as an emergent strategy for targeted cancer therapy.
Mishra LC; Pandey U; Gupta A; Gupta J; Sharma M; Mishra G
Front Mol Biosci; 2022; 9():939050. PubMed ID: 36032679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
